                         SEQUENCE LISTING

<110>  Coy, David
       Rossowski, Wojciech
 
<120>  Urotensin-II  Agonists

<130>  124P/PCT2

<150>  61/062225
<151>  2008-01-24

<160>  12    

<170>  PatentIn version 3.5

<210>  1
<211>  6
<212>  PRT
<213>  Homo sapiens

<400>  1

Cys Phe Trp Lys Tyr Cys 
1               5       


<210>  2
<211>  4
<212>  PRT
<213>  Homo sapiens

<400>  2

Phe Trp Lys Thr 
1               


<210>  3
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclic

<220>
<221>  MISC_FEATURE
<222>  (3)..(4)
<223>  methylation

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  AMIDATION

<400>  3

Asp Cys Phe Trp Lys Tyr Cys Val 
1               5               


<210>  4
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclic

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Pen (penicillamine)

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  AMIDATION

<400>  4

Asp Xaa Phe Trp Lys Tyr Cys Val 
1               5               


<210>  5
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclic

<220>
<221>  MISC_FEATURE
<222>  (7)..(8)
<223>  methylation

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  AMIDATION

<400>  5

Asp Cys Phe Trp Lys Tyr Cys Val 
1               5               


<210>  6
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(6)
<223>  cyclic

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION with succinyl group

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa = Cpa = p-chloroPhenylalanine

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  6

Cys Phe Trp Lys Xaa Cys Val 
1               5           


<210>  7
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(6)
<223>  cyclic

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION with succinyl group

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  7

Cys Phe Trp Lys Tyr Cys Thr 
1               5           


<210>  8
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclic

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  AMIDATION

<400>  8

Asp Cys Phe Trp Lys Tyr Cys Ala 
1               5               


<210>  9
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(2)
<223>  methylation

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclic

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  AMIDATION

<400>  9

Asp Cys Phe Trp Lys Tyr Cys Val 
1               5               


<210>  10
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclic

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa = Pen (penicillamine)

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  AMIDATION

<400>  10

Asp Cys Phe Trp Lys Tyr Xaa Val 
1               5               


<210>  11
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  METHYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(1)
<223>  cyclic

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  AMIDATION

<400>  11

Asp Cys Phe Trp Lys Tyr Cys Val 
1               5               


<210>  12
<211>  8
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclic

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  Val-OH

<400>  12

Asp Cys Phe Trp Lys Tyr Cys Val 
1               5               


